Pioneering the Future of Microbiome Therapeutics: Assessing Clinical Progress & Outlining Market Opportunities
Time: 8:00 am
day: Conference Day One - 7am to 10am
Details:
- Evaluating clinical progress by analysing existing approvals and late-stage clinical trial candidates
- Unlocking new market opportunities in oncology, women’s health, and metabolic disorders while navigating pharma investment trends
- Assessing the current progress of incorporating advanced technologies like AI-driven microbiome analysis, synthetic biology, and scalable manufacturing to accelerate innovation
